GPR30 forms an integral part of E2-protective pathway in experimental autoimmune encephalomyelitis

Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry

Volumn 11, Issue 4, 2011, Pages 262-274

  Bodhankar, Sheetal ^a   Offner, Halina ^b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

17 estradiol; Dendritic cells; EAE; Encephalitogenic t cells; ER ; ER ; Estrogen; G 1; G 15; GPR30; IL 10; IL 17; Inflammation; MS; Tregs

Indexed keywords

CD14 ANTIGEN; CORTICOSTEROID; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETHINYLESTRADIOL; G PROTEIN COUPLED RECEPTOR 30; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; PROGESTERONE; TESTOSTERONE; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEMBRANE; CYTOKINE RELEASE; DEMYELINATION; DENDRITIC CELL; GENE INACTIVATION; HISTOPATHOLOGY; HORMONAL REGULATION; HORMONE ACTION; IMMUNE RESPONSE; IMMUNITY; IMMUNOREGULATION; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH1 CELL; UPREGULATION;

EID: 80055110340     PISSN: 18715222     EISSN: 18756115     Source Type: Journal    
DOI: 10.2174/1871522211108040262     Document Type: Article

References (106)

1. Whitacre, C.C. Sex differences in autoimmune disease. Nat. Immunol., 2001, 2(9), 777-780.
2. Bebo, B.F., Jr.; Vandenbark, A.A.; Offner, H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res., 1996, 45(6), 680-689.
3. Voskuhl, R.R.; Pitchekian-Halabi, H.; MacKenzie-Graham, A.; McFarland, H.F.; Raine, C.S. Gender differences in autoimmune demyelination in the mouse: implications for multiple sclerosis. Ann. Neurol., 1996, 39(6), 724-733.
4. Blazkovec, A.A.; Orsini, M.W. Ontogenetic aspects of sexual dimorphism and the primary immune response to sheep erythrocytes in hamsters from prepuberty through senescence. Int. Arch. Allergy Appl. Immunol., 1976, 50(1), 55-67.
5. Garsenstein, M.; Pollak, V.E.; Kark, R.M. Systemic lupus erythematosus and pregnancy. N. Engl. J. Med., 1962, 267, 165-169.
6. Oka, M.; Vainio, U. Effect of pregnancy on the prognosis and serology of rheumatoid arthritis. Acta Rheumatol. Scand., 1966, 12(1), 47-52.
7. Confavreux, C.; Hutchinson, M.; Hours, M.M.; Cortinovis- Tourniaire, P.; Moreau, T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med., 1998, 339(5), 285-291.
8. Ostensen, M. Piroxicam in human breast milk. Eur. J. Clin. Pharmacol., 1983, 25(6), 829-830.
9. Roubinian, J.R.; Papoian, R.; Talal, N. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J. Clin. Invest., 1977, 59(6), 1066-1070.
10. Toivanen, P.; Siikala, H.; Laiho, P.; Paavilainen, T. Suppression of adjuvant arthritis by estrone in adrenalectomized and ovariectomized rats. Experientia, 1967, 23(7), 560-561.
11. Larsson, P.; Holmdahl, R. Oestrogen-induced suppression of collagen arthritis. II. Treatment of rats suppresses development of arthritis but does not affect the anti-type II collagen humoral response. Scand. J. Immunol., 1987, 26(5), 579-583.
12. Jansson, L.; Olsson, T.; Holmdahl, R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J. Neuroimmunol., 1994, 53(2), 203-207.
13. Trooster, W.J.; Teelken, A.W.; Kampinga, J.; Loof, J.G.; Nieuwenhuis, P.; Minderhoud, J.M. Suppression of acute experimental allergic encephalomyelitis by the synthetic sex hormone 17-alphaethinylestradiol: an immunological study in the Lewis rat. Int. Arch. Allergy Immunol., 1993, 102(2), 133-140.
14. Abramsky, O. Pregnancy and multiple sclerosis. Ann. Neurol., 1994, 36 Suppl, S38-S41.
15. Soldan, S.S.; Alvarez Retuerto, A.I.; Sicotte, N.L.; Voskuhl, R.R. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol., 2003, 171(11), 6267-6274.
16. Olsson, T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev., 1995, 144, 245-268.
17. Paterson, P.Y. Multiple sclerosis: an immunologic reassessment. J. Chronic Dis., 1973, 26(3), 119-126.
18. Bebo, B.F., Jr.; Fyfe-Johnson, A.; Adlard, K.; Beam, A.G.; Vandenbark, A.A.; Offner, H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol., 2001, 166(3), 2080-2089.
19. Ito, A.; Bebo, B.F., Jr.; Matejuk, A.; Zamora, A.; Silverman, M.; Fyfe-Johnson, A.; Offner, H. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol., 2001, 167(1), 542-552.
20. Paavonen, T.; Andersson, L.C.; Adlercreutz, H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J. Exp. Med., 1981, 154(6), 1935-1945.
21. Stimson, W.H.; Hunter, I.C. Proceedings: An investigation into the immunosuppressive properties of oestrogen. J. Endocrinol., 1976, 69(3), 42P-43P.
22. Prossnitz, E.R.; Oprea, T.I.; Sklar, L.A.; Arterburn, J.B. The ins and outs of GPR30: a transmembrane estrogen receptor. J. Steroid Biochem. Mol. Biol., 2008, 109(3/5), 350-353.
23. Couse, J.F.; Korach, K.S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev., 1999, 20(3), 358-417.
24. Frank, G.R. Role of estrogen and androgen in pubertal skeletal physiology. Med. Pediatr. Oncol., 2003, 41(3), 217-221.
25. Baker, L.; Meldrum, K.K.; Wang, M.; Sankula, R.; Vanam, R.; Raiesdana, A.; Tsai, B.; Hile, K.; Brown, J.W.; Meldrum, D.R. The role of estrogen in cardiovascular disease. J. Surg. Res., 2003, 115(2), 325-344.
26. Toran-Allerand, C.D. Minireview: A plethora of estrogen receptors in the brain: where will it end? Endocrinology, 2004, 145(3), 1069-1074.
27. Kovacs, E.J.; Messingham, K.A.; Gregory, M.S. Estrogen regulation of immune responses after injury. Mol. Cell. Endocrinol., 2002, 193(1/2), 129-135.
28. Czlonkowska, A.; Ciesielska, A.; Joniec, I. Influence of estrogens on neurodegenerative processes. Med. Sci. Monit., 2003, 9(10), RA247-256.
29. McEwen, B.S. Estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol., 2001, 91(6), 2785-2801.
30. Toran-Allerand, C.D.; Singh, M.; Setalo, G., Jr. Novel mechanisms of estrogen action in the brain: new players in an old story. Front. Neuroendocrinol., 1999, 20(2), 97-121.
31. Prossnitz, E.R.; Arterburn, J.B.; Smith, H.O.; Oprea, T.I.; Sklar, L.A.; Hathaway, H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol., 2008, 70, 165-190.
32. Levin, E.R. Cellular functions of plasma membrane estrogen receptors. Steroids, 2002, 67(6), 471-475.
33. Polanczyk, M.; Zamora, A.; Subramanian, S.; Matejuk, A.; Hess, D.L.; Blankenhorn, E.P.; Teuscher, C.; Vandenbark, A.A.; Offner, H. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptoralpha. Am. J. Pathol., 2003, 163(4), 1599-1605.
34. Miranda, R.C.; Sohrabji, F.; Toran-Allerand, C.D. Neuronal colocalization of mRNAs for neurotrophins and their receptors in the developing central nervous system suggests a potential for autocrine interactions. Proc. Natl. Acad. Sci. USA, 1993, 90(14), 6439-6443.
35. Zwain, I.H.; Yen, S.S. Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology, 1999, 140(8), 3843-3852.
36. Arvanitis, D.N.; Wang, H.; Bagshaw, R.D.; Callahan, J.W.; Boggs, J.M. Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J. Neurosci. Res., 2004, 75(5), 603-613.
37. Sicotte, N.L.; Liva, S.M.; Klutch, R.; Pfeiffer, P.; Bouvier, S.; Odesa, S.; Wu, T.C.; Voskuhl, R.R. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol., 2002, 52(4), 421-428.
38. Voskuhl, R.R.; Palaszynski, K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist, 2001, 7(3), 258-270.
39. Bettelli, E.; Oukka, M.; Kuchroo, V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol., 2007, 8(4), 345-350.
40. Weaver, C.T.; Hatton, R.D.; Mangan, P.R.; Harrington, L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol., 2007, 25, 821-852.
41. Steinman, L. Multiple sclerosis: a two-stage disease. Nat. Immunol., 2001, 2(9), 762-764.
42. Raine, C.S.; Scheinberg, L.C. On the immunopathology of plaque development and repair in multiple sclerosis. J. Neuroimmunol., 1988, 20(2/3), 189-201.
43. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell, 2000, 101(5), 455-458.
44. Van Parijs, L.; Abbas, A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science, 1998, 280(5361), 243-248.
45. Offner, H.; Adlard, K.; Zamora, A.; Vandenbark, A.A. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest., 2000, 105(10), 1465-1472.
46. Matejuk, A.; Adlard, K.; Zamora, A.; Silverman, M.; Vandenbark, A.A.; Offner, H. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J. Neurosci. Res., 2001, 65(6), 529-542.
47. Martin, R.; McFarland, H.F.; McFarlin, D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol., 1992, 10, 153-187.
48. Matejuk, A.; Dwyer, J.; Zamora, A.; Vandenbark, A.A.; Offner, H. Evaluation of the effects of 17beta-estradiol (17beta-e2) on gene expression in experimental autoimmune encephalomyelitis using DNA microarray. Endocrinology, 2002, 143(1), 313-319.
49. Klinkert, W.E.; Kojima, K.; Lesslauer, W.; Rinner, W.; Lassmann, H.; Wekerle, H. TNF-alpha receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol., 1997, 72(2), 163-168.
50. Polanczyk, M.J.; Hopke, C.; Vandenbark, A.A.; Offner, H. Estrogen- mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res., 2006, 84(2), 370-378.
51. Polanczyk, M.J.; Hopke, C.; Huan, J.; Vandenbark, A.A.; Offner, H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J. Neuroimmunol., 2005, 170(1/2), 85-92.
52. Polanczyk, M.J.; Hopke, C.; Vandenbark, A.A.; Offner, H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol., 2007, 19(3), 337-343.
53. Wang, C.; Dehghani, B.; Li, Y.; Kaler, L.J.; Vandenbark, A.A.; Offner, H. Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology, 2009, 126(3), 329-335.
54. Liu, H.B.; Loo, K.K.; Palaszynski, K.; Ashouri, J.; Lubahn, D.B.; Voskuhl, R.R. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol., 2003, 171(12), 6936-6940.
55. Vegeto, E.; Belcredito, S.; Etteri, S.; Ghisletti, S.; Brusadelli, A.; Meda, C.; Krust, A.; Dupont, S.; Ciana, P.; Chambon, P.; Maggi, A. Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc. Natl. Acad. Sci. USA, 2003, 100(16), 9614-9619.
56. Polanczyk, M.J.; Jones, R.E.; Subramanian, S.; Afentoulis, M.; Rich, C.; Zakroczymski, M.; Cooke, P.; Vandenbark, A.A.; Offner, H. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol., 2004, 165(6), 2069-2077.
57. Tiwari-Woodruff, S.; Morales, L.B.; Lee, R.; Voskuhl, R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. USA, 2007, 104(37), 14813-14818.
58. Jones, R.E.; Kaler, L.; Murphy, S.; Offner, H. Tissue-dependent expression of estrogen receptor beta in 17beta-estradiol-mediated attenuation of autoimmune CNS inflammation. Open Autoimmun. J., 2010, 2, 197-204.
59. Pietras, R.J.; Szego, C.M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature, 1977, 265(5589), 69-72.
60. Evinger, A.J.; Levin, E.R. Requirements for estrogen receptor alpha membrane localization and function. Steroids, 2005, 70(5/7), 361-363.
61. Razandi, M.; Pedram, A.; Merchenthaler, I.; Greene, G.L.; Levin, E.R. Plasma membrane estrogen receptors exist and functions as dimers. Mol. Endocrinol., 2004, 18(12), 2854-2865.
62. Pappas, T.C.; Gametchu, B.; Watson, C.S. Membrane estrogen receptors identified by multiple antibody labeling and impededligand binding. FASEB J., 1995, 9(5), 404-410.
63. Pedram, A.; Razandi, M.; Levin, E.R. Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol., 2006, 20(9), 1996-2009.
64. Razandi, M.; Alton, G.; Pedram, A.; Ghonshani, S.; Webb, P.; Levin, E.R. Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol. Cell Biol., 2003, 23(5), 1633-1646.
65. Acconcia, F.; Ascenzi, P.; Bocedi, A.; Spisni, E.; Tomasi, V.; Trentalance, A.; Visca, P.; Marino, M. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17betaestradiol. Mol. Biol. Cell, 2005, 16(1), 231-237.
66. Marino, M.; Ascenzi, P. Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation. Steroids, 2008, 73(9/10), 853-858.
67. Rai, D.; Frolova, A.; Frasor, J.; Carpenter, A.E.; Katzenellenbogen, B.S. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells. Mol. Endocrinol., 2005, 19(6), 1606-1617.
68. Madak-Erdogan, Z.; Kieser, K.J.; Kim, S.H.; Komm, B.; Katzenellenbogen, J.A.; Katzenellenbogen, B.S. Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol. Endocrinol., 2008, 22(9), 2116-2127.
69. Matthews, J.; Gustafsson, J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv., 2003, 3(5), 281-292.
70. Ogawa, S.; Inoue, S.; Watanabe, T.; Hiroi, H.; Orimo, A.; Hosoi, T.; Ouchi, Y.; Muramatsu, M.The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem. Biophys. Res. Commun., 1998, 243(1), 122-126.
71. Acconcia, F.; Totta, P.; Ogawa, S.; Cardillo, I.; Inoue, S.; Leone, S.; Trentalance, A.; Muramatsu, M.; Marino, M. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling. J. Cell. Physiol., 2005, 203(1), 193-201.
72. Carmeci, C.; Thompson, D.A.; Ring, H.Z.; Francke, U.; Weigel, R.J. Identification of a gene (GPR30) with homology to the Gprotein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. Genomics, 1997, 45(3), 607-617.
73. O'Dowd, B.F.; Nguyen, T.; Marchese, A.; Cheng, R.; Lynch, K.R.; Heng, H.H.; Kolakowski, L.F., Jr.; George, S.R. Discovery of three novel G-protein-coupled receptor genes. Genomics, 1998, 47(2), 310-313.
74. Owman, C.; Blay, P.; Nilsson, C.; Lolait, S.J. Cloning of human cDNA encoding a novel heptahelix receptor expressed in Burkitt's lymphoma and widely distributed in brain and peripheral tissues. Biochem. Biophys. Res. Commun., 1996, 228(2), 285-292.
75. Takada, Y.; Kato, C.; Kondo, S.; Korenaga, R.; Ando, J. Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress. Biochem. Biophys. Res. Commun., 1997, 240(3), 737-741.
76. Filardo, E.J.; Quinn, J.A.; Bland, K.I.; Frackelton, A.R., Jr. Estrogen- induced activation of Erk-1 and Erk-2 requires the G proteincoupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HBEGF. Mol. Endocrinol., 2000, 14(10), 1649-1660.
77. Revankar, C.M.; Cimino, D.F.; Sklar, L.A.; Arterburn, J.B.; Prossnitz, E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science, 2005, 307(5715), 1625-1630.
78. Thomas, P.; Pang, Y.; Filardo, E.J.; Dong, J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology, 2005, 146(2), 624-632.
79. Funakoshi, T.; Yanai, A.; Shinoda, K.; Kawano, M.M.; Mizukami, Y. G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane. Biochem. Biophys. Res. Commun., 2006, 346(3), 904-910.
80. Brailoiu, E.; Dun, S.L.; Brailoiu, G.C.; Mizuo, K.; Sklar, L.A.; Oprea, T.I.; Prossnitz, E.R.; Dun, N.J. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J. Endocrinol., 2007, 193(2), 311-321.
81. Sakamoto, H.; Matsuda, K.; Hosokawa, K.; Nishi, M.; Morris, J.F.; Prossnitz, E.R.; Kawata, M. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology, 2007, 148(12), 5842-5850.
82. Wang, C.; Prossnitz, E.R.; Roy, S.K. Expression of G proteincoupled receptor 30 in the hamster ovary: differential regulation by gonadotropins and steroid hormones. Endocrinology, 2007, 148(10), 4853-4864.
83. Gobeil, F.; Fortier, A.; Zhu, T.; Bossolasco, M.; Leduc, M.; Grandbois, M.; Heveker, N.; Bkaily, G.; Chemtob, S.; Barbaz, D. Gprotein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can. J. Physiol. Pharmacol., 2006, 84(3/4), 287-297.
84. Olde, B.; Leeb-Lundberg, L.M. GPR30/GPER1: searching for a role in estrogen physiology. Trends Endocrinol. Metab., 2009, 20(8), 409-416.
85. Blasko, E.; Haskell, C.A.; Leung, S.; Gualtieri, G.; Halks-Miller, M.; Mahmoudi, M.; Dennis, M.K.; Prossnitz, E.R.; Karpus, W.J.; Horuk, R. Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis. J. Neuroimmunol., 2009, 214(1/2), 67-77.
86. Kanda, N.; Watanabe, S. 17Beta-estradiol enhances the production of nerve growth factor in THP-1-derived macrophages or peripheral blood monocyte-derived macrophages. J. Invest. Dermatol., 2003, 121(4), 771-780.
87. Rettew, J.A.; McCall, S.H., 4th.; Marriott, I. GPR30/GPER-1 mediates rapid decreases in TLR4 expression on murine macrophages. Mol. Cell. Endocrinol., 2010, 328(1/2), 87-92.
88. Olsen, N.J.; Kovacs, W.J. Gonadal steroids and immunity. Endocr. Rev., 1996, 17(4), 369-384.
89. Wang, C.; Dehghani, B.; Magrisso, I.J.; Rick, E.A.; Bonhomme, E.; Cody, D.B.; Elenich, L.A.; Subramanian, S.; Murphy, S.J.; Kelly, M.J.; Rosenbaum, J.S.; Vandenbark, A.A.; Offner, H. GPR30 contributes to estrogen-induced thymic atrophy. Mol. Endocrinol., 2008, 22(3), 636-648.
90. Windahl, S.H.; Andersson, N.; Chagin, A.S.; Martensson, U.E.; Carlsten, H.; Olde, B.; Swanson, C.; Moverare-Skrtic, S.; Savendahl, L.; Lagerquist, M.K.; Leeb-Lundberg, L.M.; Ohlsson, C. The role of the G protein-coupled receptor GPR30 in the effects of estrogen in ovariectomized mice. Am. J. Physiol. Endocrinol. Metab., 2009, 296(3), E490-496.
91. Martensson, U.E.; Salehi, S.A.; Windahl, S.; Gomez, M.F.; Sward, K.; Daszkiewicz-Nilsson, J.; Wendt, A.; Andersson, N.; Hellstrand, P.; Grande, P.O.; Owman, C.; rosen, C.J.; Adamo, M.L.; Lundquist, I.; Rorsman, P.; Nilsson, B.O.; Ohlsson, C.; Olde, B.; Leeb- Lundberg, L.M. Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology, 2009, 150(2), 687-698.
92. Otto, C.; Rohde-Schulz, B.; Schwarz, G.; Fuchs, I.; Klewer, M.; Brittain, D.; Langer, G.; Bader, B.; Prelle, K.; Nubbemeyer, R.; Fritzemeier, K.H. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology, 2008, 149(10), 4846-4856.
93. Isensee, J.; Meoli, L.; Zazzu, V.; Nabzdyk, C.; Witt, H.; Soewarto, D.; Effertz, K.; Fuchs, H.; Gailus-Durner, V.; Busch, D.; Adler, T.; de Angelis, M.H.; Irgang, M.; Otto, C.; Noppinger, P.R. Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice. Endocrinology, 2009, 150(4), 1722-1730.
94. Erlandsson, M.C.; Ohlsson, C.; Gustafsson, J.A.; Carlsten, H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology, 2001, 103(1), 17-25.
95. Langer, G.; Bader, B.; Meoli, L.; Isensee, J.; Delbeck, M.; Noppinger, P.R.; Otto, C. A critical review of fundamental controversies in the field of GPR30 research. Steroids, 2010, 75(8/9), 603-610.
96. Qiu, J.; Bosch, M.A.; Tobias, S.C.; Krust, A.; Graham, S.M.; Murphy, S.J.; Korach, K.S.; Chambon, P.; Scanlan, T.S.; Ronnekleiv, O.K.; Kelly, M.J. A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J. Neurosci., 2006, 26(21), 5649-5655.
97. Revankar, C.M.; Mitchell, H.D.; Field, A.S.; Burai, R.; Corona, C.; Ramesh, C.; Sklar, L.A.; Arterburn, J.B.; Prossnitz, E.R. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol., 2007, 2(8), 536-544.
98. Bologa, C.G.; Revankar, C.M.; Young, S.M.; Edwards, B.S.; Arterburn, J.B.; Kiselyov, A.S.; Parker, M.A.; Tkachenko, S.E.; Savchuck, N.P.; Sklar, L.A.; Oprea, T.I.; Prossnitz, E.R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol., 2006, 2(4), 207-212.
99. Dennis, M.K.; Burai, R.; Ramesh, C.; Petrie, W.K.; Alcon, S.N.; Nayak, T.K.; Bologa, C.G.; Leitao, A.; Brailoiu, E.; Deliu, E.; Dun, N.J.; Sklar, L.A.; Hathaway, H.J.; Arterburn, J.B.; Oprea, T.I.; Prossnitz, E.R. In vivo effects of a GPR30 antagonist. Nat. Chem. Biol., 2009, 5(6), 421-427.
100. Keir, M.E.; Francisco, L.M.; Sharpe, A.H. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 2007, 19(3), 309-314.
101. Zhang, B.; Subramanian, S.; Dziennis, S.; Jia, J.; Uchida, M.; Akiyoshi, K.; Migliati, E.; Lewis, A.D.; Vandenbark, A.A.; Offner, H.; Hurn, P.D. Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke. J. Immunol., 2010, 184(8), 4087-4094.
102. Pozzi, S.; Benedusi, V.; Maggi, A.; Vegeto, E. Estrogen action in neuroprotection and brain inflammation. Ann. NY Acad. Sci., 2006, 1089, 302-323.
103. Vagnerova, K.; Koerner, I.P.; Hurn, P.D. Gender and the injured brain. Anesth. Analg., 2008, 107(1), 201-214.
104. Subramanian, S.; Matejuk, A.; Zamora, A.; Vandenbark, A.A.; Offner, H. Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J. Immunol., 2003, 170(3), 1548-1555.
105. Fotherby, K. Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapy. Contraception, 1996, 54(2), 59-69.
106. Yates, M.A.; Li, Y.; Chlebeck, P.J.; Offner, H. GPR30, but not estrogen receptor-alpha, is crucial in the treatment of experimental autoimmune encephalomyelitis by oral ethinyl estradiol. BMC Immunology, 2010, 11(20), 1-5.